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The aim of this study was to evaluate the effects of taurine and chocolate milk
supplementation on oxidative stress and protein metabolism markers, and aerobic
parameters in triathletes.
Methods: A double-blind, crossover study was conducted with 10 male triathletes,
aged 30.9 ± 1.3 year, height 1.79 ± 0.01m and body weight 77.45 ± 2.4 kg. Three
grams of taurine and 400 ml of chocolate milk (TAUchoc), or a placebo (chocolate milk)
(CHOC) was ingested post exercise for 8 weeks. Oxidative stress marker levels, and 24 h
urinary nitrogen, creatinine, and urea excretion were measured before and after 8 weeks
of training and supplementation with TAUchoc or CHOC. A maximal incremental running
test on a treadmill was performed in order to evaluate aerobic parameters: Vmax, heart
rate (HR) and rate of perceived exertion (RPE).
Results: TAUchoc treatment during the 8 weeks resulted in increased taurine plasma
levels (PRE 201.32 ± 29.03 µmol/L and POST 234.36 ± 35.51 µmol/L, p = 0.01),
decreased malondialdehyde levels (19.4%, p = 0.03) and urinary nitrogen excretion
(−33%, p = 0.03), and promoted positive nitrogen balance (p = 0.01). There were
no changes in reduced glutathione (TAUchoc PRE 0.72 ± 0.08 mmol/L and POST
0.83 ± 0.08 mmol/L; CHOC PRE 0.69 ± 0.08 mmol/L and POST 0.81 ± 0.06 mmol/L),
vitamin E plasma levels (TAUchoc PRE 33.99 ± 2.52 µmol/L and 35.95 ± 2.80 µmol/L
and CHOC PRE 31.48 ± 2.12 µmol/L and POST 33.77 ± 3.64 µmol/L), or aerobic
parameters, which were obtained in the last phase of the maximal incremental running
test (Vmax TAUchoc PRE 13 ± 1.4 km/h and POST 13.22 ± 1.34 km/h; CHOC PRE
13.11 ± 2.34 km/h and POST 13.11 ± 2.72 km/h), the heart rate values were TAUchoc
PRE 181.89 ± 24.18 bpm and POST 168.89 ± 46.56 bpm; CHOC PRE 181.56 ± 2.14
bpm and POST 179.78 ± 3.4 bpm, and the RPE were TAUchoc PRE 8.33 ± 2.4 AU
and POST 9.1 ± 2.1 AU; CHOC PRE 8.11 ± 4.94 AU and POST 8.78 ± 2.78 AU).
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Conclusion: Taurine supplementation did not improve aerobic parameters, but was
effective in increasing taurine plasma levels and decreasing oxidative stress markers,
which suggests that taurine may prevent oxidative stress in triathletes.
Keywords: triathlon, taurine, chocolate milk and aerobic parameters
INTRODUCTION
Triathlon is a high intensity sport associated with increased
production of free radicals and oxidative stress, which may
compromise an athlete’s performance (Bentley et al., 2008). This
increase occurs naturally and it is well established that low-to-
moderate levels of oxidants play multiple regulatory roles in
cells, such as cell signaling (Powers and Jackson, 2008). However,
overproduction of free radicals may damage cellular components.
Therefore, the use of antioxidant compounds post exercise
aims to prevent oxidative stress without limiting free radical
production (Powers and Jackson, 2008). In order to minimize
the effects of exercise, researchers are examining nutrients that
may help prevent oxidative damage while also contributing to an
athlete’s higher energy requirements. Taurine has been referred to
as a potent antioxidant due to the presence of sulfonic acid, which
promotes the conversion of highly cytotoxic substances including
chloride and hypochlorous acid into relatively stable chloramine
(Tappaz, 2004; Zhang et al., 2004). Additionally hypotaurine, a
taurine precursor, can act as a hydroxyl radical (OH·) scavenger
and inhibit lipid peroxidation, and therefore prevent iron (Fe+2 )
self-oxidation (Tadolini et al., 1995).
Furthermore, taurine is proposed to generate several
physiological effects including regulation of calcium homeostasis
in both skeletal muscle and cardiac tissue (Huxtable, 1992; De
Luca et al., 2015), increased muscle force (Schaffer et al., 2010),
improved lipid metabolism (Murakami, 2015), and increased
insulin sensitivity (Vettorazzi et al., 2014). In addition taurine
may improve carbohydrate metabolism and favor glycogen
resynthesis (Ribeiro et al., 2010). In addition, some researchers
have observed an improved time to exhaustion in runners (Lee
et al., 2003) and cyclists (Zhang et al., 2004; Rutherford et al.,
2010) with taurine supplementation.
According to De Luca et al. (2015) taurine supplementation
increases the amino acid levels in skeletal muscle, promotes
greater force, and improves resistance and recovery. These
actions are related to an increase in calcium binding protein
(calsequestrin1), which maintains high quantities of calcium
in the sarcoplasmic reticulum, promoting higher availability
of calcium for muscle contraction. Taurine is important to
keep excitation-contraction coupling and muscle performance;
however, the mechanisms that elucidate how taurine affects
human endurance performance and the appropriate doses are
still unclear (Galloway et al., 2008; De Luca et al., 2015).
Long period intervention studies with human requires
attention especially in the dose, since it have to be safe for the
participants. Even if there were no negative effects described in
the literature about using more than 3 g of taurine, our research
group decided to use an amount that has been used in past studies
and showed positive effects and that is higher than those studies
(1 g by Geib et al., 1994; 1.66 g by Rutherford et al., 2010; 2 g by
Ra et al., 2015). Moreover, others studies that used more than 3 g
did acute interventions (6 g by Zhang et al., 2004; Ishikura et al.,
2008).
Additionally chocolate milk has been found to be an effective
post exercise recovery aid for athletes (Karp et al., 2006; Pritchett
et al., 2009; Gilson et al., 2010), due to it ideal carbohydrate
and protein content that is similar to over the counter recovery
beverages. Thus, it has also been suggested to be effective for
replenishing depleted glycogen in the muscles (Lunn et al., 2012),
enhancing recovery after high intensity exercise when muscle
cells are more sensitive to nutrient uptake (Pritchett et al., 2009),
and may improve body composition (Ferguson-Stegall et al.,
2011). In addition, chocolate milk tastes good and is generally
acceptable for athletes (Karp et al., 2006; Pritchett et al., 2009).
The provision of specific nutrients, such as taurine, associated
with a post exercise recovery beverage, such as chocolate milk,
may be effective in preventing oxidative stress and promoting
recovery. Therefore, this study has two purposes, (1) to examine
the effectiveness of the association of taurine with low fat
chocolate milk post exercise for an 8-week period on markers
of oxidative stress and protein catabolism, and (2) to examine
the efficacy of taurine combined with low fat chocolate milk post
exercise on aerobic capacity in triathletes.
METHODS
Subjects
Ten well-trained male, long distance triathletes (age = 30.9
± 1.3 years., stature = 1.79 ± 0.01 m, mass = 77.45 ± 2.4
kg; mean ± SD) who competed in semiprofessional triathlons
volunteered to take part in this study. Their training was focused
on the Brazilian Ironman Championships. The participants were
invited to visit the lab where all experimental procedures and
associated risks and benefits were explained. Those who agreed
to participate were asked to provide written consent. Approval
for this study was granted by the Human Ethics Committee
of the State University of Sao Paulo (approval number CAAE
06191512.9.0000.5426).
Participants were excluded if they had experienced muscle
injury in the past 6 months and/or were currently taking chronic
or daily doses of anti-inflammatory medication or nutritional
supplements. Participants who had a history of cardiovascular
diseases were excluded from the study (McBrier et al., 2010).
Participants were instructed to maintain their habitual diet
throughout the study and to record their diet 1 day before
performing the data collection and 3 days during the trials.
Experimental Design
A double blind, crossover with 2-week washout study design was
conducted. Participants were assigned to one of two independent
supplementation groups: Taurine + Chocolate milk (TAUchoc)
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and Placebo + Chocolate milk (CHOC). The study consisted of
an 8-week supplementation period.
Subjects were required to attend the laboratory eight times.
On the first visit (PRE), the participants arrived at the laboratory
in the morning after a 12 h overnight fast. Anthropometric
measures including height, weight, and blood samples were
taken and body fat percentage was determined by the deuterium
method (Schoeller et al., 1980). The participants were asked to
collect 24 h urine on the day before the data collection. After
all procedures were completed, the first period of treatment
was started. A maximal incremental running test was performed
to determine aerobic capacity. Following the 8 weeks of
supplementation with taurine or placebo, the subjects were
invited to the lab to re-perform all evaluations (POST). A 2-
week wash out was allowed and then the protocol was repeated
with the other supplementation (PRE and POST second trial)
(Figure 1).
After the baseline measurements, the subjects began the
treatment with 3 grams of taurine (Aminoethylsulfonic Acid,
99% pure, Ajinomoto R©) (Shao and Hathcock, 2008), or a placebo
(starch), in capsules orally combined with low fat chocolate milk
(CM) (400 ml) (Pepsico Co, Sao Paulo, SP) immediately after
practice and again 2 hours post exercise, daily for 8 weeks.
After a 2-week washout period, the protocol was repeated with
the other treatment (taurine or placebo capsules). During the
supplementation period, subjects were asked not to change
their dietary habits and continue their triathlon training. The
participants were required to record daily training, including data
about hours and training zone, in order to calculate training load
during each treatment. The training load results were reported in
arbitrary units (au).
The low fat CM (Low Fat, Pepsico Chocolate milk, ready
to drink, Sao Paulo, SP) contained 92 kcal, 16 grams of
carbohydrate, 4 grams of protein and 1.2 grams of lipids
per serving (200 ml). The CM was selected considering the
optimal ratio of carbohydrate to protein (4:1), in order to
favor glycogen resynthesis (Ivy et al., 2003; Kerksick and
Leutholtz, 2005). In addition, CM presents a good taste and
high acceptability by athletes (Karp et al., 2006; Pritchett et al.,
2009).
Taurine Supplementation
The supplementation consisted of capsules containing 3 grams of
pure taurine (Aminoethylsulfonic Acid, Ajinomoto R©, São Paulo,
SP) (Shao and Hathcock, 2008), or a placebo. The placebo
consisted of a similar capsule containing starch. Subjects received
three capsules daily (taurine or placebo) and 200 ml of low
fat chocolate milk (CM) (LowFat Chocolate milk Pepsico, Sao
Paulo, SP) (92 kcal, 16 g carbohydrate, 4 g protein, and 1.2 g
fat) immediately after exercise and a further 200 ml of CM 1
h post exercise for a total of 60 days. After a 2-week washout
period, the protocol was repeated with the other supplementation
(taurine or placebo capsules). Taurine and placebo capsules were
manipulated by the Department of Industrial Pharmacy of the
School of Medicine of Ribeirão Preto, University of São Paulo.
Dietetic Assessment
Subjects were instructed to complete a 3-day food record and
record dietary intake on the day before data collection and three
non-consecutive days during each trial, in order to control for
dietary intake. ESHA software (Esha Research Inc, Salem, OR)
was used to examine kcal, carbohydrate, protein, and fat content.
Measurements
Taurine Assay
Plasma taurine was determined by high-performance liquid
chromatography (Shimadzu, model LC 10AD). Taurine 99% was
used as standard (Sigma-Aldrich, St. Louis, MO, USA) following
the method of Deyl et al. (1986).
Oxidative Stress Markers
Blood was collected in 5 ml tubes containing separator and clot
activating gel at PRE and POST supplementation after a 12-h fast.
The samples were then stored in a freezer at −80◦C until further
analysis. The following oxidative stress markers indicative of
lipid peroxidation were determined: reduced glutathione (GSH)
according to the method of Sedlak and Lindsay (1968) and
malondialdehyde (MDA) using the method proposed by Gerard-
Monnier et al. (1998), with some adaptations. Blood vitamin
E (total α-tocopherol) was determined by the method of α-
tocopherol (Fabianek et al., 1968).
FIGURE 1 | Schematic representation of the experimental trial. Subjects reported to the lab for an introductory visit, and then at PRE I the first treatment was started.
After 8-weeks of treatment, all the measurements were repeated (POST I). A 2-week wash out was implemented between treatments, and then the protocol was
repeated with the other treatment (PRE II and POST II).
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Protein Metabolism
Twenty-four hour urine samples were collected PRE and POST
each trial in order to quantify urinary excretion of nitrogen,
creatinine and urea. Total nitrogen excretion was determined
using 20 µL of 24-h diluted in 1,000 µl of distillated water
using a chemiluminescence nitrogen analyzer according to the
method proposed by Grimble et al. (1988). The nitrogen balance
was calculated considering total nitrogen excretion and protein
intake [NB= (Protein intake (g)/6.25) – Total nitrogen excretion
(g) + 4 (g)] (Mendley and Majkowski, 2000). Creatinine and
urea concentrations were determined by colorimetric reaction
with a spectrophotometer using a Creatinine and Urea CEkit
(Labtestdiagnóstica R©).
Aerobic Parameters
All subjects performed a maximal incremental running test
with 1% gradient on a treadmill (Super ATL, Inbramed, Brazil)
in a controlled environment. The test began at 8 km·h−1and
speed was increased by 1 km·h−1 every 3 min until volitional
exhaustion. Immediately after each stage, capillary blood samples
from the ear lobe (25 µl) were assessed and blood lactate
concentration was determined using a lactate analyzer (YSI 2300,
Yellow Springs, Ohio, USA). A heart rate (HR) monitor (Polar,
RS400, Finland) was used to measure heart rate and a 0–10
Foster’s scale (Foster et al., 2001) to determine rate of perceived
exertion (RPE) for each stage.
Lactate threshold intensity (LT) was determined using the
D-max method, in which the points obtained through the
speed, lactate concentration relationship were adjusted linearly
and exponentially, the greatest distance between these two
adjustments corresponded to anaerobic threshold intensity
(Cheng et al., 1992). Maximum aerobic velocity (Vmax) was
determined as the final completed stage during the incremental
protocol.
Statistical Analysis
A t-test was used to compare percentage change (1%POST-PRE,
TAUchoc vs. CHOC) between post and pre-supplementation for
oxidative stress markers (MDA, GSH, and Vitamin E), taurine
levels, and aerobic parameters between trials. Dietary assessment
data from the two-supplementation protocols was compared
with a t-test for independent samples. The paired t-test was used
to compare changes within the trials. In cases of non-parametric
distribution, the Wilcoxon test was used for comparisons within
trials, and the Mann-Whitney test for comparisons between
trials. Statistical Package for the Social Sciences (SPSS) for
Windows software, version 15.0, was used for all statistical
analyses. All data are reported as means ± standard deviation.
Statistical significance was set at p < 0.05 for all analyses.
RESULTS
Participant characteristics are reported as means ± SD for each
participant as follows: age (years): 30.9 ± 1.3, height (cm): 179.0
± 0.01, weight (kg): 77.45 ± 2.4, body fat mass: 15% ± 1.5, and
body lean mass: 85% ± 1.4. According to the dietary analysis,
there were no significant differences in kcal or macronutrient
intake (carbohydrate, protein, and fat). The TAUchoc group
consumed, on average, 2,243.7 ± 770.7 kcal, 4.29 ± 1.35 g/kg
of body weight (BW) of carbohydrate, 1.78 ± 0.57 g/kg BW of
protein, and 0.89 ± 0.28 g/kg BW of lipids, while the CHOC
group consumed, on average, 2,122.6 ± 702.4 kcal, 4.17 ± 1.31
g/kg BW of carbohydrate, 1.61 ± 0.51 g/kg BW of protein and
0.91± 0.23 g/kg BW of lipids.
With regard to plasma concentration of taurine in the
TAUchoc and CHOC groups there was no difference in baseline
concentrations (p = 0.68). A significant increase in taurine
plasma levels was observed with TAUchoc supplementation (PRE
201.32± 29.03 µmol/L and POST 234.36± 35.51, p= 0.01), but
not with CHOC supplementation PRE 208.51 ± 38.04 µmol/L
and POST 191.71 ± 24.96 µmol/L, (p = 0.21) after 8 weeks of
supplementation.
No significant changes were found in GSH or vitamin E
levels between trials (TAUchoc and CHOC) and comparing
PRE to POST supplementation (Table 1). However, a significant
decrease (−21%) was observed in MDA levels after TAUchoc
supplementation (p = 0.03), suggesting that taurine prevented
lipid peroxidation.
TABLE 1 | Oxidative stress and protein metabolism marker levels PRE and POST supplementation (TAUchoc and CHOC).
Measurements TAUchoc CHOC
PRE POST 1% (POST-PRE) PRE POST 1% (POST-PRE)
GSH (mmol/L) 0.72 ± 0.08 0.83 ± 0.08 16.94 0.69 ± 0.08 0.81 ± 0.06 24.24
Vitamin E (µmol/L) 33.99 ± 2.52 35.95 ± 2.80 6.54 31.48 ± 2.12 33.77 ± 3.64 6.54
MDA (µMl) 3.62 ± 0.64 2.86 ± 0.05 −21* 4.38 ± 0.60 4.30 ± 0.64 −0.46
N ur (g/day) 26.91 ± 3 16.70 ± 1.9** −37.9** 24.2 ± 2.7 20.20 ± 1.90 −16.5
Urea (g/24 h) 37.53 ± 3.80 29.34 ± 2.5 −21.9 32.04 ± 4.85 37.91 ± 6.87 18.32
Creatinine (mg/Kg/24 h) 28.14 ± 2.68 22.06 ± 2.97 −21.06 23.05 ± 2.26 26.73 ± 1.98 15.9
NB (g/24h) −4.84 ± −1.4 6.20 ± 1.79# 228.1 1.24 ± 0.36 4.91 ± 1.42 295.9
GSH, reduced glutathione; MDA, malondialdehyde; N ur, 24 h nitrogen excretion; NB, nitrogen balance. TAUchoc, taurine associated with chocolate milk supplementation; CHOC,
chocolate milk and placebo supplementation; ∆% (POST-PRE), percentage change post to pre supplementation; PRE, pre supplementation; POST, post supplementation. *Significant
decrease was observed in MDA levels post TAUchoc treatment. **Significant decrease in relation to CHOC group (pared t test, p ≤ 0.05). #significant increase was observed in NB
post TAUchoc treatment. Data reported as means ± SD. n = 10.
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A significant reduction in 24 h urinary nitrogen excretion
was observed following the TAUchoc treatment (p = 0.03) and
the percentage variation was higher post TAUchoc treatment
(−37.9%) when compared to CHOC treatment (−16.5%)
(Table 1) (p= 0.03). Nitrogen balance was calculated considering
protein intake and total urinary nitrogen excretion. Although no
significant differences were found in protein intake, a significant
change was observed in nitrogen balance following TAUchoc
treatment (p = 0.01), changing from negative (−4.84 ± 1.4 g/24
h) to positive (6.20± 1.79 g/24 h).
Regarding the aerobic parameters, which were obtained in the
last phase of the maximal incremental running test, no significant
changes were observed for Vmax(TAUchoc PRE 13 ± 1.4 km/h
and POST 13.22± 1.34 km/h; CHOCPRE 13.11± 2.34 km/h and
POST 13.11 ± 2.72 km/h). Heat rate (HR) values were TAUchoc
PRE 181.89 ± 24.18 bpm and POST 168.89 ± 46.56 bpm;
CHOC PRE 181.56± 2.14 bpm and POST 179.78± 3.4 bpm, and
the RPE values were TAUchoc PRE 8.33 ± 2.4 AU and POST 9.1
± 2.1 AU; CHOC PRE 8.11± 4.94 AU and POST 8.78± 2.78 AU.
Figure 2 displays a relative percentage calculated considering the
variable values at LT compared to values at Vmax; it was found
that the groups were similar before starting the supplementation
and there were no significant changes in aerobic parameters post
supplementation for either group (TAUchoc and CHOC).
DISCUSSION
The main purpose of this study was to examine the additive
effects of TAUchoc vs. CHOC on indices of oxidative stress,
protein catabolism, and aerobic capacity in triathletes. Exercise
performance was assessed using an incremental running test. Our
results suggest that supplementation with taurine or a placebo
associated with low fat chocolate milk for an 8-week period
did not improve aerobic performance, however the taurine with
FIGURE 2 | Relative percentage change calculated considering the variable
values at LT compared to values at Vmax (n = 10). This graph shows that
groups were similar before starting the supplementation and no changes were
observed when analyzing pre and post values at LT compared to values at
Vmax. CHOC, chocolate milk and placebo treatment. TAUchoc, Taurine and
chocolate milk treatment. LT Speed, Speed at lactate threshold. HR: heart
rate. RPE, rate of perceived exertion. Vmax, maximum aerobic velocity. No
changes were observed post TAUchoc and CHOC supplementation.
chocolate milk (TAUchoc) provided benefits to oxidative stress
markers and increased taurine plasma levels, demonstrating that
the supplementation protocol was effective.
Regarding oxidative stress, moderate training appears to
benefit health and oxidative stress since exercise stimulus is
necessary to promote up-regulation in endogenous antioxidant
defenses (Pingitore et al., 2015), however strenuous aerobic
exercise such as triathlon, can induce reactive oxygen species
overproduction and may cause oxidative damage if the
endogenous defense is not effective, thereby compromising
athletic performance (Hawley, 2009). Therefore, utilization of
antioxidant compounds post exercise aim to prevent oxidative
stress and possibly enhance performance (Kim and Lee, 2014;
Pingitore et al., 2015).
Also, taurine has been considered in the scientific literature
a nutraceutical compound due to its various beneficial effects
on human health (Xu et al., 2008) such as the treatment of
fatigue and myotonia (Trip et al., 2006), visual protection in
diabetics (Yu et al., 2008), immunocompetence improvement
(Grimble, 2006), anti-neurotoxic and anti-inflammatory effects,
and tumor cell proliferation inhibition (Schuller-Levis and Park,
2003; Grimble, 2006; Klusa et al., 2006; Marcinkiewicz et al.,
2006). Therefore, taurine supplementation can benefit athletes
metabolism by the modulation of the inflammatory process and
oxidative stress.
The results of the present study indicated that taurine
supplementation was effective in decreasing lipid peroxidation
due to a 21% reduction in MDA levels after TAUchoc treatment,
however no changes were found in antioxidant markers (GSH
and Vitamin E). Even though the results were not significant,
it is important to note that the average levels of GSH and
α-tocopherol post treatment were higher in the TAUchoc
supplementation than the CHOC supplementation. These results
suggest that TAUchoc supplementation prevented the utilization
of GSH and vitamin E against free radicals and improved the
activities of the antioxidant defense system.
Similar results were found by Zhang et al. (2004) who
evaluated the effects of 7-day taurine supplementation (6
g/day) on oxidative stress induced by exercise in cyclists, and
concluded that taurine decreased levels of thiobarbituric acid
reactive substances (TBARS), which are also indicators of lipid
peroxidation. Silva et al. (2011) investigated the effects of a 15-
day taurine supplementation (300 mg/kg) or saline on oxidative
stress biomarkers after a 90-min downhill run session in rats
and concluded that taurine affected skeletal muscle contraction
by decreasing oxidative stress (superoxide radical production,
creatine kinase, lipid peroxidation, and carbonylation levels),
however no changes were found in the antioxidant enzyme
activity after the exercise protocol (Silva et al., 2011).
It was expected that taurine may improve athletes
performance. According to Dutka et al. (2014), taurine can
improve muscle function and blood lactate levels by the
following mechanisms: (1) an interaction between the skeletal
muscle membrane and taurine; (2) an increase of calcium release
to contractile filaments of skeletal muscle, which enhances
force production; (3) an increase of mitochondrial buffering.
In addition, Ward et al. (1999) suggested that the intensity and
Frontiers in Physiology | www.frontiersin.org 5 September 2017 | Volume 8 | Article 710
De Carvalho et al. Taurine: A Potential Ergogenic Aid for Triathletes
speed performed during exercise are strongly correlated with
high taurine levels, possibly indicating its release of muscle fibers
(Ward et al., 1999).
Also, some studies suggested that the high levels of taurine
may reflect changes in the electrophysical properties of skeletal
muscle membrane or in blood osmolarity due to its co-release
with water to maintain plasma volume and calcium homeostasis
(Ward et al., 1999, 2016; Spriet andWhitfield, 2015). In addition,
taurine is related to lactic acid buffering in brain and skeletal
muscle cells in rats (Nakada et al., 1991). However, the blood
lactate levels post exercise remained unaltered after taurine
supplementation in athletes (Lee et al., 2003; Rutherford et al.,
2010).
In addition, Pierno et al. (2012) showed an important action
of taurine on muscular dysfunction, especially on the skeletal
muscle disuse-induced impairment, which is related to the
reduction of taurine content in postural muscles. The authors
verified that taurine supplementation restored the expression
of an atrophy-related gene (i.e., Muscle RING-Finger Protein
1/MuRF-1) in rats, suggesting a beneficial role of taurine in the
prevention of disuse-induced skeletal muscle atrophy.
However, in the present study improvements in performance
were not observed, since that no significant changes were
detected in aerobic parameters post TAUchoc and CHOC
supplementation. It is important to highlight that, even though
not significant, a short increase in Vmax (0.15 Km/h) POST
compared to PRE TAUchoc and a decrease in HR with post
TAUchoc were observed in the maximal incremental running
test performed. These results indicate that taurine may have
improved cardiorespiratory response during exercise. Therefore,
TAUchoc treatment may offer some practical performance
benefits, especially when observing the results of the last Ironman
Brazil race, which took place in Florianópolis city, Brazil, where
the time difference to finish the race between the first and second
places was 18 min and 6 s, and between the second and third
places was 42 s (Ironman Brasil, 2016). Therefore, small increases
in performance, mainly the speed developed during a race, may
result in success in the race, which suggests that a triathlete
who runs 0.15 km/h faster than another athlete post TAUchoc
treatment may win a race even if the difference in the speed
performed along the race between de winner and the second place
athlete is not statistically significant.
Other researchers investigated a cycling time trial
performance (5 kJ of work/kg body mass as fast as possible) with
taurine supplementation and did not demonstrate improvement
in performance (11). Controversially, Balshaw et al. (2013)
investigated the effect of acute ingestion of 1 g of taurine
on maximal 3 km time trial (3KTT) performance in trained
middle-distance runners, and found that the ingestion of taurine
improved 3KTT performance by 1.7%.
Concerning time of administration, according to
Ghandforoush-Sattari et al. (2010), maximum plasma taurine
concentration may be reached 1.5 ± 0.6 h post administration.
Therefore, the TAUchoc treatment was expected to increase
the availability and utilization of nutrients post exercise and
consequently stimulate glycogen synthesis and promote protein
synthesis. In the present study, the results related to urinary
protein metabolism showed that TAUchoc supplementation
induced lower urinary nitrogen excretion and positive nitrogen-
balance. The nitrogen-balance demonstrates how much nitrogen
is coming into the body and how much is being excreted. A
positive nitrogen balance indicates that more nitrogen is being
retained than excreted, which suggests that muscle is being
gained (Benardot, 2006).
Although other authors have shown changes in urea levels
post intense exercise training (Benardot, 2006), the present study
did not find changes in urea levels after TAUchoc and CHOC and
8 weeks of triathlon practice. Conversely, with different sports
modalities, no significant changes in urinary urea levels were
found after a periodized training in a study with soccer players
(Silva et al., 2006) and cyclists (Halson et al., 2002). According to
Halson et al. (2002) creatinine and urea can be used as markers
of muscle damage, changes in lean body mass, and dehydration.
Since no changes were found in urea and creatinine levels,
and nitrogen balance was positive after TAUchoc treatment, the
results of the present study suggest that taurine can contribute to
preservation of muscle mass and may favor muscle recovery by
ensuring adequate nutrient supply to muscle cells post exercise.
Although no significant treatment effects were observed
in the aerobic parameters, our results indicate that there
may be potential performance benefits attributed to taurine
supplementation. From a practical perspective, an increase of
1% in the speed was observed in the LT of the subjects in the
TAUchoc group when comparing with the test speed developed
before treatment (PRE). Therefore, the association of taurine
and chocolate milk as a post exercise recovery beverage may
offer practical performance benefits for an athlete during a
competition.
CONCLUSION
The results of the present study indicated that taurine
supplementation did not improve aerobic parameters, but was
effective in increasing taurine plasma levels and decreasing
oxidative stress markers, which suggests that taurine may prevent
oxidative stress in triathletes. Additional studies are warranted
to examine the potential advantages of taurine supplementation
on indices of exercise recovery and muscle damage, since some
evidence of performance improvement was observed in the
present study.
AUTHOR CONTRIBUTIONS
FGDC, BSMG, PCS, and ECF design of the work; acquisition,
analysis and interpretation of data for the work; paper writing;
KeP, KaP, EF, MP, JSM, and ECF analysis and interpretation
of data for the work, critical revising for important intellectual
content; and final approval of the version to be published.
FUNDING
Financial support for research development from FAPESP
(process number 2013/05620-7) and CAPES.
Frontiers in Physiology | www.frontiersin.org 6 September 2017 | Volume 8 | Article 710
De Carvalho et al. Taurine: A Potential Ergogenic Aid for Triathletes
ACKNOWLEDGMENTS
The authors would like to thank Ajinomoto (São
Paulo, SP) for providing the taurine powder, and
Gilberto João Padovan, Paula Payão Ovídio, Simone
Sakagute Tavares, and Ronaldo Buchen Gobbi for
technical support in laboratory analyzes and performance
tests.
REFERENCES
Balshaw, T. G., Bampouras, T. M., Barry, T. J., and Sparks, S. A. (2013). The effect
of acute taurine ingestion on 3-km running performance in trained middle-
distance runners. Amino Acids. 44, 555–561. doi: 10.1007/s00726-012-1372-1
Benardot, D. (2006). “Nutrition sources for athletes,” in Advanced Sports Nutrition
(Champaign, IL: Human Kinetics), 3–35.
Bentley, D. J., Cox, G. R., Green, D., and Laursen, P. B. (2008). Maximising
performance in triathlon: applied physiological and nutritional aspects
of elite and non-elite competitions. J. Sci. Med. Sport. 11, 407–416.
doi: 10.1016/j.jsams.2007.07.010
Cheng, B., Kuipers, H., Snyder, A. C., Keizer, H. A., Jeukendrup, A., and Hesselink,
M. (1992). A new approach for the determination of ventilatory and lactate
thresholds. Int. J. Sports Med. 13, 518–522. doi: 10.1055/s-2007-1021309
De Luca, A., Pierno, S., and Camerino, D. C. (2015). Taurine: the appeal of
a safe amino acid for skeletal muscle disorders. J. Transl. Med. 13:243.
doi: 10.1186/s12967-015-0610-1
Deyl, Z., Hyanek, J., and Horakova, M. (1986). Profiling of amino acids in body
fluids and tissues by means of liquid chromatography. J. Chromatogr. 379,
177–250. doi: 10.1016/S0378-4347(00)80685-4
Dutka, T. L., Lamboley, C. R., Murphy, R.M., and Lamb, G. D. (2014). Acute effects
of taurine on sarcoplasmic reticulum Ca2+ accumulation and contractility in
human type I and type II skeletal muscle fibres. J. Appl. Physiol. 117, 797–905.
doi: 10.1152/japplphysiol.00494.2014
Fabianek, J., DeFilippi, J., Richards, T., and Herp, A. (1968). Micromethod for
tocopherol determination in blood serum. Clin. Chem. 14, 456–462.
Ferguson-Stegall, L., McCleave, E. L., Ding, Z., Doerner, P. G., Wang,
B., Liao, Y. H., et al. (2011). Postexercise carbohydrate-protein
supplementation improves subsequent exercise performance and intracellular
signaling for protein synthesis. J. Strength Cond. Res. 25, 1210–1224.
doi: 10.1519/JSC.0b013e318212db21
Foster, C., Florhaug, J. A., Franklin, J., Gottschall, L., Hrovatin, L. A., Parker, S.,
et al. (2001). A new approach to monitoring exercise training. J. Strength. Cond.
Res. 15, 109–111. doi: 10.1519/00124278-200102000-00019
Galloway, S. D., Talanian, J. L., Shoveller, A. K., Heigenhauser, G. J., and Spriet,
L. L. (2008). Seven days of oral taurine supplementation does not increase
muscle taurine content or alter substrate metabolism during prolonged exercise
in humans. J. Appl. Physiol. 105, 643–651. doi: 10.1152/japplphysiol.90525.2008
Geib, K. R., Jester, I., Falke, W., Hamm, M., and Waag, K. L. (1994). The effect of
a taurine-containing drink on performance in 10 endurance-athletes. Amino
Acids. 7, 45–56.
Gerard-Monnier, D., Erdelmeier, I., Regnard, K., Moze-Henry, N., Yadan,
J. C., and Chaudiere, J. (1998). Reactions of 1-methyl-2-phenylindole
with malondialdehyde and 4-hydroxyalkenals. analytical applications to a
colorimetric assay of lipid peroxidation. Chem. Res. Toxicol. 11, 1176–1183.
doi: 10.1021/tx9701790
Ghandforoush-Sattari, M., Mashayekhi, S., Krishna, C. V., Thompson, J. P., and
Routledge, P. A. (2010). Pharmacokinetics of oral taurine in healthy volunteers.
J. Amino Acids. 2010:346237. doi: 10.4061/2010/346237
Gilson, S. F., Saunders, M. J., Moran, C. W., Moore, R. W., Womack, C. J., and
Todd, M. K. (2010). Effects of chocolate milk consumption on markers of
muscle recovery following soccer training: a randomized cross-over study. J.
Int. Soc. Sports Nutr. 7:19. doi: 10.1186/1550-2783-7-19
Grimble, G. K., West, M. F., Acuti, A. B., Rees, R. G., Hunjan, M. K., Webster,
J. D., et al. (1988). Assessment of an automated chemiluminescence nitrogen
analyzer for routine use in clinical nutrition. J. Parenter. Enteral. Nutr. 12,
100–106. doi: 10.1177/0148607188012001100
Grimble, R. F. (2006). The effects of sulfur amino acids intake on immune function
in humans. J. Nutr. 136, 1660S–1665S.
Halson, S. L., Bridge, M. W., Meeusen, R., Busschaert, B., Gleeson, M., Jones, D.
A., et al. (2002). Time course of performance changes and fatigue markers
during intensified training in trained cyclists. J. Appl. Physiol. 93, 947–956.
doi: 10.1152/japplphysiol.01164.2001
Hawley, J. A. (2009). Molecular responses to strength and endurance
training: are they incompatible? Appl. Physiol. Nutr. Metab. 34, 355–361.
doi: 10.1139/H09-023
Huxtable, R. J. (1992). Physiological actions of taurine. Physiol. Rev. 72, 101–163.
Ironman Brasil (2016). Available online at: http://www.ironmanbrasil.com.br/
2016/for/br/resultado.php.
Ishikura, K., Miyakawa, S., Yatabe, Y., Takekoshi, K., and Omori, H. (2008). Effect
of taurine supplementation in blood glucose concentration during prolonged
exercise. Jpn. J. Phys. Fit. Sports Med. 57, 475–484. doi: 10.7600/jspfsm.57.475
Ivy, J. L., Res, P. T., Sprague, R. C., and Widzer, M. O. (2003). Effect
of a carbohydrate-protein supplement on endurance performance during
exercise of varying intensity. Int. J. Sport Nutr. Exerc. Metab. 13, 382–395.
doi: 10.1123/ijsnem.13.3.382
Karp, J. R., Johnston, J. D., Tecklenburg, S., Mickleborough, T. D., Fly, A. D., and
Stager, J. M. (2006). Chocolate milk as a post-exercise recovery aid. Int. J. Sport.
Nutr. Exerc. Metab. 16, 78–91. doi: 10.1123/ijsnem.16.1.78
Kerksick, C. M., and Leutholtz, B. (2005). Nutrient administration and resistance
training. J. Int. Soc. Sports Nutr. 2, 50–67. doi: 10.1186/1550-2783-2-1-50
Kim, J., and Lee, J. (2014). A review of nutritional intervention on delayed onset
muscle soreness. Part I. J. Exerc. Rehabil. 10, 349–356. doi: 10.12965/jer.140179
Klusa, V., Klimaviciusa, L., Duburs, G., Poikans, J., and Zharkovsky, A. (2006).
Anti-neurotoxic effects of tauropyrone, a taurine analogue.Adv. Exp. Med. Biol.
583, 499–508. doi: 10.1007/978-0-387-33504-9_56
Lee, H. M., Park, I. Y., and Park, T. S. (2003). Effects of dietary supplementation of
taurine, carnitine or glutamine on endurance exercise performance and fatigue
parameters in athletes. Korean J. Nutr. 36, 711–719.
Lunn, W. R., Pasiakos, S. M., Colletto, M. R., Karfonta, K. E., Carbone, J.
W., Anderson, J. M., et al. (2012). Chocolate milk and endurance exercise
recovery: protein balance, glycogen, and performance. Med. Sci. Sports Exerc.
44,682–691. doi: 10.1249/MSS.0b013e3182364162
Marcinkiewicz, J., Kurnyta, M., Biedron, R., Bobek, M., Kontny, E.,
and Maslinski, W. (2006). Anti-inflammatory effects of taurine
derivatives (taurine chloramine, taurine bromamine, and taurolidine) are
mediated by different mechanisms. Adv. Exp. Med. Biol. 583, 481–492.
doi: 10.1007/978-0-387-33504-9_54
McBrier, N. M., Vairo, G. L., Bagshaw, D., Lekan, J. M., Bordi, P. L., Kris-Etherton,
P. M. (2010). Cocoa-based protein and carbohydrate drink decreases perceived
soreness after exhaustive aerobic exercise: a pragmatic preliminary analysis. J.
Strength Cond. Res. 24, 2203–2210. doi: 10.1519/JSC.0b013e3181e4f7f9
Mendley, S. R., and Majkowski, N. L. (2000). Urea and nitrogen excretion
in pediatric peritoneal dialysis patients. Kidney Int. 58, 2564–2570.
doi: 10.1046/j.1523-1755.2000.00442.x
Murakami, S. (2015). Role of taurine in the pathogenesis of obesity. Mol. Nutr.
Food. Res. 59, 1353–1363. doi: 10.1002/mnfr.201500067
Nakada, T., Hida, K., and Kwee, I. L. (1991). pH-lactate dissociation
during anoxic insult: taurine effect. Neuro Report. 2, 325–328.
doi: 10.1097/00001756-199106000-00006
Pierno, S., Liantonio, A., Camerino, G. M., De Bellis, M., Cannone, M., Gramegna,
G., et al. (2012). Potential benefits of taurine in the prevention of skeletal muscle
impairment induced by disuse in the hindlimb-unloaded rat. Amino Acids 43,
431–445. doi: 10.1007/s00726-011-1099-4
Pingitore, A., Lima, G. P., Mastorci, F., Quinones, A., Iervasi, G., and Vassalle,
C. (2015). Exercise and oxidative stress: potential effects of antioxidant
dietary strategies in sports. Nutrition 31, 916–922. doi: 10.1016/j.nut.2015.
02.005
Frontiers in Physiology | www.frontiersin.org 7 September 2017 | Volume 8 | Article 710
De Carvalho et al. Taurine: A Potential Ergogenic Aid for Triathletes
Powers, S. K., and Jackson, M. J. (2008). Exercise-induced oxidative stress:
cellular mechanisms and impact on muscle force production. Physiol. Rev. 88,
1243–1276. doi: 10.1152/physrev.00031.2007
Pritchett, K., Bishop, P., Pritchett, R., Green, M., and Katica, C. (2009). Acute
effects of chocolate milk and a commercial recovery beverage on postexercise
recovery indices and endurance cycling performance. Appl. Physiol. Nutr.
Metab. 34, 1017–1022. doi: 10.1139/H09-104
Ra, S. G., Akazawa, N., Choi, Y., Matsubara, T., Oikawa, S., Kumagai, H., et al.
(2015). Taurine supplementation reduces eccentric exercise-induced delayed
onset muscle soreness in young men. Adv. Exp. Med. Biol. 803, 765–772.
doi: 10.1007/978-3-319-15126-7_61
Ribeiro, R. A., Vanzela, E. C., Oliveira, C. A., Bonfleur, M. L., Boschero, A.
C., and Carneiro, E. M. (2010). Taurine supplementation: involvement of
cholinergic/phospholipase C and protein kinase A pathways in potentiation of
insulin secretion and Ca2+ handling in mouse pancreatic islets. Br. J. Nutr. 104,
1148–1155. doi: 10.1017/S0007114510001820
Rutherford, J. A., Spriet, L. L., and Stellingwerff, T. (2010). The effect
of acute taurine ingestion on endurance performance and metabolism
in well-trained cyclists. Int. J. Sport. Nutr. Exerc. Metab. 20, 322–329.
doi: 10.1123/ijsnem.20.4.322
Schaffer, S. W., Jong, C. J., Ramila, K. C., and Azuma, J. (2010). Physiological
roles of taurine in heart and muscle. J. Biomed. Sci. 17(Suppl. 1):S2.
doi: 10.1186/1423-0127-17-S1-S2
Schoeller, D. A., Van Santen, E., Peterson, D.W., Dietz, W., Jaspan, J., and Klein, P.
D. (1980). Total body water measurement in humans with 18O and 2H labeled
water. Am. J. Clin. Nutr. 33, 2686–2693.
Schuller-Levis, G. B., and Park, E. (2003). Taurine: new implications
for an old amino acid. FEMS Microbiol. Lett. 226, 195–202.
doi: 10.1016/S0378-1097(03)00611-6
Sedlak, J., and Lindsay, R. H. (1968). Estimation of total, protein-
bound, and nonprotein sulfhydryl groups in tissue with Ellman’s
reagent. Anal. Biochem. 25, 192–205. doi: 10.1016/0003-2697(68)
90092-4
Shao, A., and Hathcock, J. N. (2008). Risk assessment for the amino acids
taurine, L-glutamine and L-arginine. Regul. Toxicol. Pharmacol. 50, 376–399.
doi: 10.1016/j.yrtph.2008.01.004
Silva, A. S. R., Santhiago, V., Papoti, M., and Gobatto, C. A. (2006).
Comportamento das concentrações séricas e urinárias de creatinina e uréia ao
longo de uma periodização desenvolvida em futebolistas profissionais: relações
com a taxa de filtração glomerular. Rev. Bras. Med. Esporte. 12, 327–332.
doi: 10.1590/S1517-86922006000600006
Silva, L. A., Silveira, P. C., Ronsani, M. M., Souza, P. S., Scheffer, D., Vieira,
L. C., et al. (2011). Taurine supplementation decreases oxidative stress in
skeletal muscle after eccentric exercise. Cell. Biochem. Funct. 29, 43–49.
doi: 10.1002/cbf.1716
Spriet, L. L., and Whitfield, J. (2015). Taurine and skeletal muscle
function. Curr. Opin. Clin. Nutr. Metab. Care 18, 96–101.
doi: 10.1097/MCO.0000000000000135
Tadolini, B., Pintus, G., Pinna, G. G., Bennardini, F., and Franconi, F. (1995).
Effects of taurine and hypotaurine on lipid peroxidation. Biochem. Biophys. Res.
Commun. 213, 820–826. doi: 10.1006/bbrc.1995.2203
Tappaz, M. L. (2004). Taurine biosynthetic enzymes and taurine transporter:
molecular identification and regulations. Neurochem. Res. 29, 83–96.
doi: 10.1023/B:NERE.0000010436.44223.f8
Trip, J., Drost, G., van Engelen, B. G., and Faber, C. G. (2006). Drug
treatment for myotonia. Cochrane Database Syst. Rev. CD004762.
doi: 10.1002/14651858.CD004762.pub2
Vettorazzi, J. F., Ribeiro, R. A., Santos-Silva, J. C., Borck, P. C., Batista, T. M.,
and Nardelli, T. R. (2014). Taurine supplementation increases K(ATP) channel
protein content, improving Ca2+ handling and insulin secretion in islets
from malnourished mice fed on a high-fat diet. Amino Acids. 46, 2123–2136.
doi: 10.1007/s00726-014-1763-6
Ward, R., Bridge, C. A., McNaughton, L. R., and Sparks, S. A. (2016). The effect
of acute taurine ingestion on 4-km time trial performance in trained cyclists.
Amino Acids 48, 2581–2587. doi: 10.1007/s00726-016-2282-4
Ward, R. J., Francaux,M., Cuisinier, C., Sturbois, X., andDe,W. P. (1999). Changes
in plasma taurine levels after different endurance events. Amino Acids 16,
71–77. doi: 10.1007/BF01318886
Xu, Y. J., Arneja, A. S., Tappia, P. S., and Dhalla, N. S. (2008). The potential health
benefits of taurine in cardiovascular disease. Exp. Clin. Cardiol. 13, 57–65
Yu, X., Xu, Z., Mi, M., Xu, H., Zhu, J., Wei, N., et al. (2008). Dietary taurine
supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of
glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res. 33,
500–507. doi: 10.1007/s11064-007-9465-z
Zhang, M., Izumi, I., Kagamimori, S., Sokejima, S., Yamagami, T., and
Liu, Z. (2004). Role of taurine supplementation to prevent exercise-
induced oxidative stress in healthy young men. Amino Acids 26, 203–207.
doi: 10.1007/s00726-003-0002-3
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 De Carvalho, Galan, Santos, Pritchett, Pfrimer, Ferriolli, Papoti,
Marchini and de Freitas. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 8 September 2017 | Volume 8 | Article 710
